BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021

BIEL +23.33%  Frederick, Maryland, Jan. 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to report that Q4 revenue for 2020 exceeded $519,000, representing an increase of 241% when compared to Q3 revenue in 2020 ($151,956). Correspondingly, Q4 2020 revenue represents an increase of 233% when compared to the cumulative revenue of … Continue Reading

BioElectronics’ ActiPatch® Therapy To Be Marketed By DonJoy® Advantage

Drug-Free Pain Relief Technology with Premium Wraps FREDERICK, Md.,  Nov. 6, 2020 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL),  www.bielcorp.comis pleased to announce the execution of a commercial partnership agreement with Scott Specialties Inc (SS to bring their innovative pain management devices to the retail consumer healthcare marketplace under the DonJoy® (DJO Advantage product line. This commercial … Continue Reading

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

FREDERICK, MD- February 3, 2020 – BioElectronics Corporation (OTC PINK: BIEL),, the maker of non-invasive electroceutical devices, is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA).  This new, over-the counter marketing clearance was granted for the drug free ActiPatch® medical device, for the … Continue Reading